Edition:
United Kingdom

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

1.25USD
18 Jan 2019
Change (% chg)

$-0.01 (-0.79%)
Prev Close
$1.26
Open
$1.28
Day's High
$1.33
Day's Low
$1.17
Volume
47,585
Avg. Vol
17,122
52-wk High
$2.18
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

Neurometrix Reports Agreement With GSK Healthcare On 2019 Quell Development Program
Tuesday, 11 Dec 2018 

Dec 11 (Reuters) - NeuroMetrix Inc ::NEUROMETRIX REPORTS AGREEMENT WITH GSK HEALTHCARE ON 2019 QUELL JOINT DEVELOPMENT PROGRAM AND MODIFICATION TO STRATEGIC COLLABORATION.PARTIES MODIFIED TERMS OF COLLABORATION TO REALLOCATE UP TO $13.8 MILLION REMAINING TO BE PAID BY GSK.REPORTED AGREEMENT REACHED ON 2019 DEVELOPMENT PROGRAM AND IT WILL COMMENCE IN JANUARY 2019.MODIFICATIONS ACCELERATED PORTION OF REMAINING MILESTONES TIMING INTO NEXT 12 MONTHS.NEUROMETRIX RECEIVED A $2 MILLION MILESTONE PAYMENT FROM GSK IN CONNECTION WITH MODIFICATIONS.MODIFICATIONS REDUCED AGGREGATE MILESTONE AMOUNT PAYABLE BY AN INTEREST CHARGE.  Full Article

NeuroMetrix Q1 Revenue Rose 15 Percent To $4.9 Million
Thursday, 19 Apr 2018 

April 19 (Reuters) - NeuroMetrix Inc ::NEUROMETRIX REPORTS Q1 2018 FINANCIAL RESULTS.Q1 REVENUE ROSE 15 PERCENT TO $4.9 MILLION.QTRLY NET INCOME WAS $1.2 MILLION IN COMPARISON WITH A NET LOSS OF $3.2 MILLION IN Q1 2017.  Full Article

Neurometrix Reports Preliminary 2017 Financial Highlights
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Neurometrix Inc ::NEUROMETRIX REPORTS PRELIMINARY 2017 FINANCIAL HIGHLIGHTS.NEUROMETRIX INC - PRELIMINARY GAAP REVENUE FOR Q4 OF 2017 IS ESTIMATED AT APPROXIMATELY $4.9 MILLION IN COMPARISON WITH $3.7 MILLION IN Q4 2016.  Full Article